Further discovery of anti-tissue transglutaminase (tTG) as the substrate for AEA, tTG based enzyme-linked immunoassays (ELISA) became the standard diagnostic test for CeD [10]. This evidence concerns the gene TGM2 and cranioectodermal dysplasia.